UPDATE 1-Otonomy's ear drug fails mid-stage trial, shares slide

May 21 (Reuters) - Otonomy Inc said its experimental drug did not meet the main goal of reducing the incidence of vertigo in a mid-stage trial in patients suffering from Ménière's disease.